SARS-CoV-2 Spike RBD Neutralizing Antibody, monoclonal, Chimeric

• Catalog Number: orb1274221
• Category: Antibodies
• Description: SARS-CoV-2 Spike RBD Neutralizing Antibody, monoclonal, Chimeric
• Clonality: Recombinant
• Tested applications: ELISA, WB
• Reactivity: Mouse
• Isotype: Human IgM/kappa
• Immunogen: Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM is isolated from a SARS-CoV-2 infected patient and is recombinantly produced from human 293 cells (HEK293).
• Concentration: batch dependent
• Form/Appearance: Lyophilized
• Conjugation: Unconjugated
• Target: S
• UniProt ID: P0DTC2
• Storage: For long term storage, the product should be stored at lyophilized state at -20°C or lower.Please protect from light and avoid repeated freeze-thaw cycles.This product is stable after storage at:-20°C to -70°C for 12 months in lyophilized state;-70°C for 3 months under sterile conditions after reconstitution.
• Buffer/Preservatives: Lyophilized from 0.22 um filtered solution in PBS, pH 7.4 , Contact us for customized product form or formulation.
• Alternative names: spike glycoprotein
• Note: For research use only
• Expiration Date: 12 months from date of receipt.

Anti-SARS-CoV-2 Spike RBD Neutralizing antibody, Human IgM on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.

Immobilized Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM at 2 ug/mL (100 uL/well) can bind SARS-CoV-2 S protein RBD, His Tag with a linear range of 0.6-2.4 ng/mL (QC tested).

Serial dilutions of Anti-SARS-CoV-2 Spike RBD Neutralizing Antibody, Chimeric mAb, Human IgM was detected by Biotinylated Human ACE2, His